全球更年期市场规模、份额、成长分析、按应用程式、按最终用户 - 产业预测，2024-2031 年

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

出版日期: 2024年04月28日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

到2022年，全球更年期市场价值将达到169亿美元，从2023年的178亿美元成长到2031年的269.7亿美元，预测期内（2024-2031年）复合年增长率为5.3%。

女性生育年龄的结束以更年期这个生物学正常过程为标誌。闭经的典型特征是月经结束，通常在 45 岁至 55 岁之间开始。女性在更年期会经历各种症状，包括情绪低落、阴道干燥、潮热和盗汗。营养食品和其他旨在帮助控制更年期症状的产品的市场不断增长。这些产品包括成药药和处方药、草药补充品、维生素、矿物质和其他营养食品。对天然和有机产品的渴望、更年期相关健康疾病的日益流行以及人们对营养食品的健康益处的认识不断提高，预计将在未来几年对全球更年期市场做出重大贡献。此外，许多因素正在推动更年期市场的发展，包括世界人口的老化、与更年期相关的健康风险意识的增强以及对天然和有机产品日益增长的需求。此外，随着女性接近更年期，她们对健康管理越来越感兴趣，这推动了新产品和服务的创造。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Pfizer Inc.
Novo Nordisk A/S
Allergan plc
TherapeuticsMD Inc.
Mylan NV
Teva Pharmaceutical Industries Ltd.
Bayer AG
Merck & Co. Inc.
Johnson & Johnson
GlaxoSmithKline plc
Eli Lilly and Company
Amgen Inc.
AbbVie Inc.
Pfizer Inc.
Novartis International AG
Procter & Gamble Co.
Roche Holding AG
Sanofi SA
Serenity Pharmaceuticals LLC
Mithra Pharmaceuticals SA

简介目录

Product Code: SQMIG35I2115

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.3% during the forecast period (2024-2031).

The end of a woman's reproductive years is marked by the normal biological process of menopause. It is typified by the end of menstruation and typically affects people between the ages of 45 and 55. Women may have a variety of symptoms throughout menopause, such as mood swings, vaginal dryness, hot flashes, and night sweats. The market for dietary supplements and other goods intended to assist women in managing menopausal symptoms is expanding. These goods include over-the-counter and prescription drugs, as well as herbal supplements, vitamins, minerals, and other dietary supplements. The desire for natural and organic products, increased prevalence of menopause-related health disorders, and growing awareness of the health advantages of nutritional supplements are all likely to fuel considerable growth in the worldwide menopausal market in the upcoming years. A multitude of causes, such as the aging of the world's population, greater awareness of health risks associated to menopause, and an increasing desire for natural and organic products, are also driving the menopause market. Additionally, as menopause approaches, women are growing increasingly involved in overseeing their health and well-being, which is propelling the creation of new goods and services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segmental Analysis

Global Menopause Market is segmented based on treatment, and region. Based on treatment, the market is segmented into dietary supplements, OTC pharma products. Further, OTC pharma products is segmented into hormonal and non-hormonal. Based on region, the global Menopause Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Menopause Market

It is projected that the market would present a number of opportunities due to variables like the growth of non-hormonal therapies, customized medicine, and digital health solutions, as well as the tendency toward natural and herbal cures. Non-hormonal treatments are gaining popularity despite hormone replacement therapy (HRT) being the primary treatment for menopause symptoms for a considerable amount of time. There is an opportunity for pharmaceutical companies and medical practitioners to create effective non-hormonal therapies for symptoms such as mood swings, vaginal dryness, and hot flashes. Menopause affects women differently, so there is no one-size-fits-all method of treating it. The menopausal market may present a significant opportunity for individualized care that considers a woman's unique symptoms, medical background, and way of life. Additionally, wearable technology, telemedicine, and other digital health technologies may benefit women going through menopause. Digital health solutions that help women track their symptoms, get advice and support, and connect with medical specialists are an opportunity.

Restraints in the Global Menopause Market

Notwithstanding the market's enormous growth potential, obstacles include safety worries, a lack of knowledge and stigma, legal restrictions, and a dearth of R&D may prevent it from expanding. Women who utilize hormone replacement treatment (HRT) have been reported to have an increased risk of breast cancer, heart disease, and stroke. This has led to concerns about the safety of HRT and an increase in the demand for non-hormonal therapy. Businesses that specialize in hormone-based therapy would find it challenging to resolve these safety concerns. Many nations still view menopause as a taboo topic, and little is known about it or how it impacts women's health. This could lower demand and make it more difficult for companies to effectively market menopause-related products and services. Furthermore, strict regulatory regulations, particularly for hormone-based therapy, govern the menopausal industry. Companies that create new drugs and therapies must meet stringent safety and efficacy standards before receiving a license to be used. But much remains unknown about menopause and its effects on women's health. The dearth of research and development in the field may make effective treatments and therapies more difficult to come by. These are a handful of the factors that may prevent the market from growing.

Market Trends of the Global Menopause Market

A growing number of women are looking for non-hormonal therapy to manage menopause symptoms because they are concerned about the possible risks associated with hormone-based treatments. Consequently, there is a growing demand for non-hormonal therapies like CBT, herbal remedies, and mindfulness-based programs.

Telemedicine, internet forums, and smartphone apps are becoming more and more popular for treating menopausal symptoms. These choices offer privacy, comfort, and accessibility, which may be particularly appealing to women who are reluctant to seek medical attention related to menopause.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Menopause Market by Applications

Market Overview
Screening and Diagnosis

Global Menopause Market by End User

Market Overview
Hospital
Diagnostic Centres
Specialty Clinics
Others.

Global Menopause Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TherapeuticsMD Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Procter & Gamble Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serenity Pharmaceuticals LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mithra Pharmaceuticals SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments